Manufacturer record
YL Pharma: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
9 batches manufactured by YL Pharma (Himachal Pradesh) were declared Not of Standard Quality between September 2025 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
9 records linked to YL Pharma in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Paracetamol, Phenylephrine Hydrochloride Diphenhydramine, Hydrocloride & Caffeine Tablets | YLT25023Mfg 2025-06 · Exp 2027-05 | The sample does not conform to the claim with respect to in Assay of Phenylephrine Hydrochloride & Caffeine (Anhydrous) (NIL).Assay | DTL JaipurState lab | Feb 2026 |
| Levocetirizine Dihydrochloride & Montelukast Sodium Tablets IP | LT-25029Mfg 2025-09 · Exp 2027-08 | The sample does not HP conform to the IP with respect to Assay.Assay | DTL, JaipurState lab | Dec 2025 |
| Levocetirizine Dihydrochloride Tablets | YLT25023Mfg 2025-03 · Exp 2027-02 | The sample does not conform to the IP with respect to AssayAssay | DTL, JaipurState lab | Dec 2025 |
| Diclofenac Potassium & Paracetamol Tablets (MUSCARE-P TAB.) | YLT25027Mfg 2025-07 · Exp 2027-06 | Diclofeanc Potassium Assay 83.54% & Assay Of Paracetamol 79.83%Assay | DTL BADDIState lab | Dec 2025 |
| Ofloxacin Tab IP 200mg | YLT25025Mfg 2025-06 · Exp 2027-05 | The Sample Does not conform to the IP with respect to AssayAssay | DTL, JaipurState lab | Nov 2025 |
| Levocetirizine Dihydrochloride & Montelukast Sodium Tablets | YLT25029Mfg 2025-09 · Exp 2027-08 | The Sample Does not conform to the IP with respect to AssayAssay | DTL, JaipurState lab | Nov 2025 |
| Levocetirizine DiHydrochloride Tablets | YLT25028Mfg 2025-07 · Exp 2027-06 | The Sample Does not conform to the IP with respect to AssayAssay | DTL, JaipurState lab | Nov 2025 |
| Levocetirizine Dihydrochloride Tab (Wineet-L) | YLT25023Mfg 2025-03 · Exp 2027-02 | The sample does not conform to the IP as it does not contain Levocetirizine DihydrochlorideOther | DTL, JaipurState lab | Oct 2025 |
| Paracetamol, Phenylephrine Hcl, Caffeine & Diphenhydramine Hcl Tablets | YLT25006Mfg 2025-01 · Exp 2026-12 | Identification & AssayAssay | DTL ,Baddi, HPState lab | Sep 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.